Controlled Substances Act Clarification in Sciences Act of 2026

Jun 8, 2026

Summary

Updates key definitions in the Controlled Substances Act to match modern science and requires the Attorney General to follow medical advice when scheduling drugs.

What problem does this solve?

The Controlled Substances Act uses old terms that don't match today's medical knowledge, which can make it hard for scientists and doctors to use certain drugs. This bill updates these terms and makes sure that scientific and medical experts have the main say in how drugs are controlled.

What does this bill do?

Limits Attorney General's role in drug scheduling

Requires the Attorney General to follow the scientific and medical evaluation from the Secretary of Health and Human Services when deciding how to control a substance.

Defines 'accepted medical use'

Adds a new definition for 'accepted medical use' to include scientific research, uses approved by the FDA, and uses authorized by a state and recognized by medical regulators.

Updates definitions for drug dependence and abuse

Adds modern, specific definitions for terms like 'dependence liability', 'physical dependence', 'psychological dependence', and 'abuse' to guide scheduling decisions.

Requires balancing public health with medical access

Mandates that drug scheduling must be tailored to protect public health while also preserving access for accepted medical uses and recognizing potential benefits to society.

Who does this affect?

Medical researchers and scientists
Patients
Federal drug enforcement and health agencies

What is the real world impact?

•

Updates drug laws to reflect modern science

Aims to align the Controlled Substances Act with current medical and scientific understanding of drugs and their potential uses. This ensures that decisions about drug control are based on up-to-date evidence.

•

Facilitates research on restricted substances

By redefining 'accepted medical use' to include scientific research, the bill could make it easier for scientists to study Schedule I drugs for potential health benefits.

•

Reduces the Attorney General's authority over drug scheduling

Forces the Attorney General to defer to the Secretary of Health and Human Services' medical evaluation. Critics might argue this shifts power away from law enforcement and could compromise public safety.

When does this start?

This bill would take effect as soon as it is signed into law.